Literature DB >> 22864916

Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis.

Shivashankar Othy, Selma Topçu, Srini V Kaveri, Jagadeesh Bayry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864916      PMCID: PMC3443131          DOI: 10.1073/pnas.1209124109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.

Authors:  Bradley Newhouse; Shelley Allen; Benjamin Fauber; Aaron S Anderson; C Todd Eary; Joshua D Hansen; Justin Schiro; John J Gaudino; Ellen Laird; David Chantry; Christine Eberhardt; Laurence E Burgess
Journal:  Bioorg Med Chem Lett       Date:  2004-11-15       Impact factor: 2.823

2.  A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.

Authors:  Helene Pere; Yves Montier; Jagadeesh Bayry; Francoise Quintin-Colonna; Nathalie Merillon; Estelle Dransart; Cecile Badoual; Alain Gey; Patrice Ravel; Elie Marcheteau; Frederic Batteux; Federico Sandoval; Olivier Adotevi; Christopher Chiu; Sylvie Garcia; Corinne Tanchot; Yu-Chun Lone; Luis Carlos Ferreira; Brad H Nelson; Douglas Hanahan; Wolf Herman Fridman; Ludger Johannes; Eric Tartour
Journal:  Blood       Date:  2011-09-09       Impact factor: 22.113

3.  CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells.

Authors:  Karola Poppensieker; David-Marian Otte; Britta Schürmann; Andreas Limmer; Philipp Dresing; Eva Drews; Beatrix Schumak; Luisa Klotz; Jennifer Raasch; Alexander Mildner; Ari Waisman; Stefanie Scheu; Percy Knolle; Irmgard Förster; Marco Prinz; Wolfgang Maier; Andreas Zimmer; Judith Alferink
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

4.  In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.

Authors:  Jagadeesh Bayry; Elma Z Tchilian; Matthew N Davies; Emily K Forbes; Simon J Draper; Srini V Kaveri; Adrian V S Hill; Michel D Kazatchkine; Peter C L Beverley; Darren R Flower; David F Tough
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-11       Impact factor: 11.205

5.  Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.

Authors:  A Iellem; M Mariani; R Lang; H Recalde; P Panina-Bordignon; F Sinigaglia; D D'Ambrosio
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

  5 in total
  4 in total

Review 1.  The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.

Authors:  Stefanie Scheu; Shafaqat Ali; Christina Ruland; Volker Arolt; Judith Alferink
Journal:  Int J Mol Sci       Date:  2017-11-02       Impact factor: 5.923

2.  Sex differences in EAE reveal common and distinct cellular and molecular components.

Authors:  Jack Wiedrick; Roberto Meza-Romero; Grant Gerstner; Hilary Seifert; Priya Chaudhary; Ashley Headrick; Gail Kent; Ashley Maestas; Halina Offner; Arthur A Vandenbark
Journal:  Cell Immunol       Date:  2020-10-22       Impact factor: 4.868

Review 3.  Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy.

Authors:  Jagadeesh Bayry
Journal:  Virusdisease       Date:  2013-11-29

Review 4.  The role of chemokines and chemokine receptors in multiple sclerosis.

Authors:  Li-Yuan Cui; Shi-Feng Chu; Nai-Hong Chen
Journal:  Int Immunopharmacol       Date:  2020-03-18       Impact factor: 4.932

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.